Misonix, a provider of minimally invasive therapeutic ultrasonic medical devices, acquired Solsys Medical, a privately held regenerative medical company, for $109m. "We have known the team at Solsys for over two years and have been impressed in their ability to grow their revenue meaningfully during that time. The acquisition of Solsys Medical is a transformative event for Misonix and represents a strategically and financially compelling growth opportunity for the company and for our shareholders." Stavros Vizirgianakis, President and Chief Executive Officer of Misonix.